In February 2023 the India National Anti-Doping Agency (INADA) reported an anti-doping rule violation against the weightlifter Akshata Basavant Kamati after her sample tested positive for the prohibited substances Dehydrochlormethyltestosterone, Metandienone and Stanozolol.
Following notification a provisional suspension was ordered. The Athlete filed a statement in her defence and she was heard for the Anti-Doping Disciplinary Panel of India (ADDPI).
The Panel finds that the presence of prohibited substances have been established in the Athlete's sample and accordingly that she committed an anti-doping rule violation. The Panel considers that the Athlete merely denied the intentional use of the substance and requested for a reduced sanction.
Therefore the Panel decides on 16 August 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 15 February 2023.
